Protective effect of urocortin on 1-methyl-4-phenylpyridinium-induced dopaminergic neuronal death

Molecules and Cells

Volumn 30, Issue 5, 2010, Pages 427-433

  Kim, Yonjung ^a   Park, Myoung Kyu ^a   Chung, Sungkwon ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

1 methy 4 phenylpyridinium; cAMP; dopamine neuron; protein Kinase A; urocortin

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; UROCORTIN;

ARTICLE; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; NEUROPROTECTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

1-METHYL-4-PHENYLPYRIDINIUM; CELL DEATH; CELL LINE, TUMOR; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOPAMINE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; NEUROBLASTOMA; NEURONS; PHOSPHORYLATION; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; SIGNAL TRANSDUCTION; UROCORTINS;

ANIMALIA;

EID: 78650511936     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10059-010-0132-x     Document Type: Article

References (45)

1. A. Abuirmeileh R. Lever A.E. Kingsbury A.J. Lees I.C. Locke R.A. Knight H.S. Chowdrey C.S. Biggs P.S. Whitton 2007 The corticotrophin-releasing factor-like peptide urocortin reverses key deficits in two rodent models of Parkinson's disease Eur. J. Neurosci. 26 417 423 10.1111/j.1460-9568.2007.05653. x 17650114 (Pubitemid 47087603)
2. A. Abuirmeileh A. Harkavyi A. Kingsbury R. Lever P.S. Whitton 2009 The CRF-like peptide urocortin greatly attenuates loss of extracellular striatal dopamine in rat models of Parkinson's disease by activating CRF(1) receptors Eur. J. Pharmacol. 604 45 50 1:CAS:528:DC%2BD1MXhsFOms7k%3D 10.1016/j.ejphar. 2008.11.009 19026631
3. N. Bayatti J. Zschocke C. Behl 2003 Brain region-specific neuroprotective action and signaling of corticotropin-releasing hormone in primary neurons Endocrinology 144 4051 4060 1:CAS:528:DC%2BD3sXmvFWrs7c%3D 10.1210/en.2003-0168 12933679 (Pubitemid 37088760)
4. D. Blum S. Torch N. Lambeng M. Nissou A.L. Benabid R. Sadoul J.M. Verna 2001 Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease Prog. Neurobiol. 65 135 172 1:CAS:528:DC%2BD3MXkt1Kitbo%3D 10.1016/S0301-0082(01) 00003-X 11403877 (Pubitemid 32524182)
5. B.K. Brar A.K. Jonassen A. Stephanou G. Santilli J. Railson R.A. Knight D.M. Yellon D.S. Latchman 2000 Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway J. Biol. Chem. 275 8508 8514 1:CAS:528:DC%2BD3cXit1enurc%3D 10.1074/jbc.275.12.8508 10722688 (Pubitemid 30180198)
6. B.K. Brar A. Chen M.H. Perrin W. Vale 2004 Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin- releasing factor (CRF) receptors 1 and 2beta by the CRF/urocortin family of peptides Endocrinology 145 1718 1729 1:CAS:528:DC%2BD2cXis1Sisrs%3D 10.1210/en.2003-1023 14670995 (Pubitemid 38402380)
7. G. Chen K.A. Bower C. Ma S. Fang C.J. Thiele J. Luo 2004 Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death FASEB J. 18 1162 1164 1:CAS:528:DC%2BD2cXlslKkt7o%3D 10.1096/fj.03-0899com 15132987 (Pubitemid 38787591)
8. P.C. Chin N. Majdzadeh S.R. D'Mello 2005 Inhibition of GSK3beta is a common event in neuroprotection by different survival factors Brain Res. Mol. Brain Res. 137 193 201 1:CAS:528:DC%2BD2MXltFars7s%3D 10.1016/j.molbrainres. 2005.03.004 15950778 (Pubitemid 40798902)
9. G. Cibelli P. Corsi G. Diana F. Vitiello G. Thiel 2001 Corticotropin-releasing factor triggers neurite outgrowth of a catecholaminergic immortalized neuron via cAMP and MAP kinase signalling pathways Eur. J. Neurosci. 13 1339 1348 1:STN:280:DC%2BD3M3htVSqsA%3D%3D 10.1046/j.0953-816x. 2001.01510.x 11298794 (Pubitemid 32328488)
10. W.E. Courchesne R. Kunisawa J. Thorner 1989 A putative protein kinase overcomes pheromone-induced arrest of cell cycling in S. cerevisiae Cell 58 1107 1119 1:CAS:528:DyaK3cXpsFarsQ%3D%3D 10.1016/0092-8674(89)90509-6 2673544 (Pubitemid 19238188)
11. F.M. Dautzenberg S. Wille 2004 Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism Regul. Pept. 118 165 173 1:CAS:528:DC%2BD2cXhvFaju7o%3D 10.1016/j.regpep.2003. 12.012 15003833 (Pubitemid 38296730)
12. L. Facci D.A. Stevens M. Pangallo D. Franceschini S.D. Skaper P.J. Strijbos 2003 Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors Neuropharmacology 45 623 636 1:CAS:528:DC%2BD3sXms1Ort7g%3D 10.1016/S0028-3908(03)00211-9 12941376 (Pubitemid 36980819)
13. S. Gandhi N.W. Wood 2005 Molecular pathogenesis of Parkinson's disease Hum. Mol. Genet. 14 2749 2755 10.1093/hmg/ddi308 (Pubitemid 41300647)
14. J.L. Goldberg B.A. Barres 2000 The relationship between neuronal survival and regeneration Annu. Rev. Neurosci. 23 579 612 1:CAS:528:DC%2BD3cXjs1Gms7o%3D 10.1146/annurev.neuro.23.1.579 10845076 (Pubitemid 30350055)
15. D.K. Grammatopoulos H.S. Randeva M.A. Levine K.A. Kanellopoulou E.W. Hillhouse 2001 Rat cerebral cortex corticotropin-releasing hormone receptors: evidence for receptor coupling to multiple G-proteins J. Neurochem. 76 509 519 1:CAS:528:DC%2BD3MXhtVGktL0%3D 10.1046/j.1471-4159.2001.00067.x 11208914 (Pubitemid 32097028)
16. C.A. Grimes R.S. Jope 2001 The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling Prog. Neurobiol. 65 391 426 1:CAS:528:DC%2BD3MXmt1yjt7Y%3D 10.1016/S0301-0082(01)00011-9 11527574 (Pubitemid 32781670)
17. +)-induced degeneration J. Neurosci. Res. 32 190 201 1:CAS:528:DyaK38XksVWisb8%3D 10.1002/jnr.490320208 1357186
18. Huang, H.Y., Lin, S.Z., Chen, W.F., Li, K.W., Kuo, J.S., and Wang, M.J. (2009). Urocortin modulates dopaminergic neuronal survival via inhibition of glycogen synthase kinase-3beta and histone deacetylase. Neurobiol. Aging [in press].
19. +) causes DNA fragmentation and increases the Bcl-2 expression in human neuroblastoma, SH-SY5Y cells, through different mechanisms Brain Res. 704 240 245 1:CAS:528:DyaK2MXhtVSgsLvF 10.1016/0006-8993(95)01120-X 8788920 (Pubitemid 26013090)
20. J. Jacquy P. Mettens S. Blum N. Jacqmotte J.E. Vanderheyden 1993 Long-latency auditory evoked responses in Parkinson disease and in parkinsonism induced by neuroleptics Acta Neurol. Belg. 93 119 129 1:STN:280: DyaK3szkvVOquw%3D%3D 8102219 (Pubitemid 23237861)
21. S. Kelly H. Zhao G. Hua Sun D. Cheng Y. Qiao J. Luo K. Martin G.K. Steinberg S.D. Harrison M.A. Yenari 2004 Glycogen synthase kinase 3beta inhibitor Chir025 reduces neuronal death resulting from oxygen-glucose deprivation, glutamate excitotoxicity, and cerebral ischemia Exp. Neurol. 188 378 386 1:CAS:528:DC%2BD2cXlsFygu78%3D 10.1016/j.expneurol.2004.04.004 15246837 (Pubitemid 38891598)
22. 2+ channels Neurosci. Lett. 465 31 35 1:CAS:528:DC%2BD1MXhtFGkurvE 10.1016/j.neulet.2009.08.066 19729048
23. S.H. Koh M.Y. Noh S.H. Kim 2008 Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3 Brain Res. 1188 254 262 1:CAS:528:DC%2BD2sXhsVOktrjP 10.1016/j.brainres.2007.10.064 18031715 (Pubitemid 350296066)
24. M. Li X. Wang M.K. Meintzer T. Laessig M.J. Birnbaum K.A. Heidenreich 2000 Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta Mol. Cell Biol. 20 9356 9363 1:CAS:528: DC%2BD3MXivValsrk%3D 10.1128/MCB.20.24.9356-9363.2000 11094086 (Pubitemid 32246120)
25. M.A. Mena M.J. Casarejos A. Bonin J.A. Ramos J. García Yébenes 1995 Effects of dibutyryl cyclic AMP and retinoic acid on the differentiation of dopamine neurons: prevention of cell death by dibutyryl cyclic AMP J. Neurochem. 65 2612 2620 1:STN:280:DyaK28%2FmsVyntw%3D%3D 10.1046/j.1471-4159.1995.65062612.x 7595558
26. P.P. Michel Y. Agid 1996 Chronic activation of the cyclic AMP signaling pathway promotes development and long-term survival of mesencephalic dopaminergic neurons J. Neurochem. 67 1633 1642 1:CAS:528:DyaK28XmtVWitb0%3D 10.1046/j.1471-4159.1996.67041633.x 8858948 (Pubitemid 26314221)
27. +) in ventral mesencephalic-striatal co-culture in rat Neurosci. Lett. 170 191 194 1:CAS:528:DyaK2cXlt1Ohtrc%3D 10.1016/0304-3940(94)90271-2 8041505 (Pubitemid 24117319)
28. A. Mora G. Sabio R.A. Gonzalez-Polo A. Cuenda D.R. Alessi J.C. Alonso J.M. Fuentes G. Soler F. Centeno 2001 Lithium inhibits caspase 3 activation and dephosphorylation of PKB and GSK3 induced by K+ deprivation in cerebellar granule cells J. Neurochem. 78 199 206 1:CAS:528:DC%2BD3MXltVylsr0%3D 10.1046/j.1471-4159.2001.00410.x 11432986 (Pubitemid 32622601)
29. S. Mourlevat J.D. Troadec M. Ruberg P.P. Michel 2003 Prevention of dopaminergic neuronal death by cyclic AMP in mixed neuronal/glial mesencephalic cultures requires the repression of presumptive astrocytes Mol. Pharmacol. 64 578 586 1:CAS:528:DC%2BD3sXmvFaiu7w%3D 10.1124/mol.64.3.578 12920193 (Pubitemid 37048560)
30. A. Nicotra S. Parvez 2002 Apoptotic molecules and MPTP-induced cell death Neurotoxicol. Teratol. 24 599 605 1:CAS:528:DC%2BD38XmsVCit7w%3D 10.1016/S0892-0362(02)00213-1 12200191 (Pubitemid 35013521)
31. M. Pap G.M. Cooper 1998 Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway J. Biol. Chem. 273 19929 19932 1:CAS:528:DyaK1cXlsVWgsrg%3D 10.1074/jbc.273.32.19929 9685326 (Pubitemid 28377539)
32. W.A. Pedersen R. Wan P. Zhang M.P. Mattson 2002 Urocortin, but not urocortin II, protects cultured hippocampal neurons from oxidative and excitotoxic cell death via corticotropin-releasing hormone receptor type I J. Neurosci. 22 404 412 1:CAS:528:DC%2BD38XmsVKmtg%3D%3D 11784785 (Pubitemid 34049078)
33. M.H. Perrin W.W. Vale 1999 Corticotropin releasing factor receptors and their ligand family Ann. N.Y. Acad. Sci. 885 312 328 1:CAS:528: DC%2BD3cXhsVyjtA%3D%3D 10.1111/j.1749-6632.1999.tb08687.x 10816663
34. A. Riccio S. Ahn C.M. Davenport J.A. Blendy D.D. Ginty 1999 Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons Science 286 2358 2361 1:CAS:528:DC%2BD3cXjvVWk 10.1126/science.286.5448. 2358 10600750 (Pubitemid 30016901)
35. R.A. Ross J.L. Biedler 1985 Presence and regulation of tyrosinase activity in human neuroblastoma cell variants in vitro Cancer Res. 45 1628 1632 1:CAS:528:DyaL2MXhs1Clu70%3D 2983884
36. P. Schoeffter D. Feuerbach I. Bobirnac L. Gazi R. Longato 1999 Functional, endogenously expressed corticotropin-releasing factor receptor type 1 (CRF1) and CRF1 receptor mRNA expression in human neuroblastoma SH-SY5Y cells Fundam. Clin. Pharmacol. 13 484 489 1:CAS:528:DyaK1MXlt1Kisr0%3D 10.1111/j.1472-8206.1999.tb00007.x 10456290 (Pubitemid 32250273)
37. S.L. Stevens T.E. Shaw E. Dykhuizen N.S. Lessov J.K. Hill W. Wurst M.P. Stenzel-Poore 2003 Reduced cerebral injury in CRH-R1 deficient mice after focal ischemia: a potential link to microglia and atrocytes that express CRH-R1 J. Cereb. Blood Flow Metab. 23 1151 1159 1:CAS:528:DC%2BD3sXnslaqsb4%3D 10.1097/01.WCB.0000086957.72078.D4 14526225 (Pubitemid 37229518)
38. P.J. Stork J.M. Schmitt 2002 Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation Trends Cell Biol. 12 258 266 1:CAS:528:DC%2BD38Xks1emuro%3D 10.1016/S0962-8924(02)02294-8 12074885 (Pubitemid 34634174)
39. E.W. Sutherland 1972 Studies on the mechanism of hormone action Science 177 401 408 1:CAS:528:DyaE38XltlGgtr4%3D 10.1126/science.177.4047.401 4339614
40. 1/2) signaling pathway by cyclic AMP potentiates the neuroprotective effect of the neurotransmitter noradrenaline on dopaminergic neurons Mol. Pharmacol. 62 1043 1052 1:CAS:528:DC%2BD38XosVKjurY%3D 10.1124/mol.62.5.1043 12391266 (Pubitemid 35222494)
41. K. Van Kolen K. Verstraeten I. Royaux R. De Hoogt E. Gutknecht P.J. Peeters 2010 Corticotropin releasing factor-induced ERK phosphorylation in AtT20 cells occurs via a cAMP-dependent mechanism requiring EPAC2 Neuropharmacology 58 135 144 10.1016/j.neuropharm.2009.06.022 19573542
42. D.L. Vaux S.J. Korsmeyer 1999 Cell death in development Cell 96 245 254 1:CAS:528:DyaK1MXotlyqsw%3D%3D 10.1016/S0092-8674(00)80564-4 9988219 (Pubitemid 29059354)
43. M. Villalba J. Bockaert L. Journot 1997 Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogenactivated protein kinase (MAP kinase) pathway J. Neurosci. 17 83 90 1:CAS:528:DyaK2sXmsFWk 8987738 (Pubitemid 27008852)
44. P.S. Whitton 2007 Inflammation as a causative factor in the aetiology of Parkinson's disease Br. J. Pharmacol. 150 963 976 1:CAS:528:DC%2BD2sXkt1Chsr8%3D 10.1038/sj.bjp.0707167 17339843 (Pubitemid 46628616)
45. J. Xu J. Culman A. Blume S. Brecht P. Gohlke 2003 Chronic treatment with a low dose of lithium protects the brain against ischemic injury by reducing apoptotic death Stroke 34 1287 1292 1:CAS:528:DC%2BD3sXjtFGmu7Y%3D 10.1161/01.STR.0000066308.25088.64 12677021 (Pubitemid 36547530)